Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.2 to v3.6.3, indicating a maintenance update to the page. This change updates the page's version reference used for tracking edits.
    Difference
    0.0%
    Check dated 2026-07-06T16:37:54.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows an updated revision tag: v3.6.2 replacing v3.6.0. This reflects a minor page/platform update rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-06-29T08:41:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    New help and navigation items were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment. The page revision indicator was updated from Revision: v3.5.5 to Revision: v3.6.0.
    Difference
    1%
    Check dated 2026-06-15T06:59:55.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-06-08T04:18:40.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The footer revision tag updated from v3.5.3 to v3.5.4, signaling a new page build without changes to the displayed study content.
    Difference
    0.1%
    Check dated 2026-05-17T09:25:22.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site release rather than a substantive change to the trial record.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:12.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.